Market Overview

Benzinga's Top Pre-Market Gainers

Related ENVI
Stocks Hitting 52-Week Highs
Benzinga's M&A Chatter for Thursday September 10, 2015
Related POZN
Mid-Morning Market Update: Markets Open Lower; Goldman Sachs Q4 Profit Drops
POZEN And Tribute Announce Plan To Proceed With Merger To Form Aralez Pharmaceuticals, $350 Million Capital Commitment from Deerfield-Led Syndicate

Envivio (NASDAQ: ENVI) shares jumped 26.79% to $3.55 in pre-market trading after the company reported Q2 results.

Pozen (NASDAQ: POZN) shares gained 14.56% to $6.06 in the pre-market session after the company signed a licensing agreement with Sanofi's (NYSE: SNY) US unit for the marketing of PA8140 and PA32540 tablets in the US.

Groupon (NASDAQ: GRPN) soared 6.27% to $10.94 in the pre-market trading. Analysts at Morgan Stanley upgraded Groupon to “overweight.”

Astex Pharmaceuticals (NASDAQ: ASTX) surged 4.11% to $8.61 in the pre-market session after Otsuka Pharmaceutical announced its plans to buy the company for $8.50 per share in cash.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers


Related Articles (ENVI + ASTX)

View Comments and Join the Discussion!

Partner Center